bioprinting regenerative platform
BellaSeno’s Clinical Trial on 3D-Printed Breast Implants Shows Promising Early Results
Bioprinting firm BellaSeno has provided a public update on its ongoing clinical trial for resorbable breast scaffolding. The trial uses patients’ own fat with a 3D-printed scaffold, which gradually reabsorbs…
Featured
Bioprinter Maker Rokit Prepares for Korean IPO
Leading bioprinter manufacturer Rokit Healthcare is gearing up for its Initial Public Offering (IPO) as early as July 2021. In March 2021, the South Korean company announced it is preparing…